Cell Counting Kit-8 (CCK-8)
目录号 : GK10001细胞计数试剂盒-8(CCK-8)是一种即用型的单瓶溶液,可快速、可靠地测量各种化学物质对细胞存活率和毒性的敏感度。
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2023):2307193.PMID:37951210
- Adv Mater (2024):2401538.PMID:38738793
- Adv Mater (2025):2413968.PMID:40223457
- Adv Fiber Mater (2025):1-17.
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Bioact Mater 51 (2025):825-840.PMID:40678266
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Trends in Sciences 22.9 (2025):10417-10417.
- Cancer Res 85.20 (2025).PMID:40729488
- Nat Commun 15.1 (2024):72.PMID:38167723
- Cancer Res (2025).PMID:40729488
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Adv. Fiber Mater. (2025):1-17.
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Matter (2025).
- ACS nano (2025).PMID:39846120
- Nat Commun 16.1 (2025):6100.PMID:40603843
- Acs Nano (2024).PMID:39361472
- Nat Commun 16.1 (2025):6271.PMID:40623997
- Nat Commun 16.1 (2025):6532.PMID:40664636
- Nat. Commun. 16.1 (2025):7856.PMID:40846856
- Acs Nano (2025).PMID:40534228
- Nat Commun 16.1 (2025):7650.PMID:40819125
- Nat Commun 16.1 (2025):7827.PMID:40846845
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Cancer Commun (2024).PMID:38512764
- Nat Commun 16.1 (2025):6807.PMID:40707439
- Acs Nano (2025).PMID:40878028
- Nat. Commun. 16.1 (2025):2551.
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Acta Pharm Sin B (2025).
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Nat Commun 16.1 (2025):3605.PMID:40240371
- Adv Sci (2023):2301107.PMID:37097746
- Autophagy just-accepted (2024).PMID:39007910
- Adv Sci (2024):2401845.PMID:38757623
- Acta Pharm Sin B (2025).
- Brain Behav Immun (2024).PMID:38565398
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Adv Sci (2025):e02781.PMID:40886326
- Adv Sci (2024):2404365.PMID:39159143
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2025):e08503.PMID:40685704
- Adv Sci (2025):2413936.PMID:40047320
- Adv Sci (2025):2417374.PMID:40213972
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2025):e04192.PMID:40536697
- Adv Sci (2025):2417318.PMID:40472230
- Adv Sci (2024):2402450.PMID:38952061
- Adv Sci (2025):2417374.PMID:40213972
- Advanced Science (2025):e08503.PMID:40685704
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- Exp Mol Med (2025):1-15.PMID:40887495
- Science Advances 11.31 (2025):eadx6732.PMID:40737412
- Water Res (2024):121379.PMID:38422694
- Nano Today 61 (2025):102560.
- Microbiome 13.1 (2025):1-19.PMID:41063317
- Theranostics 15.15 (2025):7802.PMID:40756352
- Theranostics 15.15 (2025):7802.PMID:40756352
- Theranostics 15.15 (2025):7820.PMID:40756354
- Biomaterials 325 (2026):123539.PMID:40664088
- Biomaterials (2025):123335.PMID:40222258
- Small (2024):2407674.PMID:39363789
- Sci Adv 11.33 (2025):eadx3851.PMID:40802748
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- Small 21.3 (2025):2409121.PMID:39544127
- J Nanobiotechnol 23.1 (2025):643.PMID:41074154
- J Nanobiotechnol (2025).PMID:40691611
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- J Nanobiotechnol 23.1 (2025):537.PMID:40707955
- J Nanobiotechnol 23.1 (2025):533.PMID:40691611
- J Adv Res (2025).PMID:40373960
- Carbohyd Polym (2025):124445.
- Theranostics 15.14 (2025):6919.PMID:40585994
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Biomaterials (2025):123539.PMID:40664088
- J Adv Res (2023).PMID:36933884
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Small Methods (2024):2400223.PMID:38602202
- J Hazard Mater (2024):135904.PMID:39303616
- Mol. Ther. 33.3 (2025):1134.PMID:39810420
- Engineering-Prc (2025).
- Redox Biol (2025):103771.PMID:40669208
- Theranostics 12.7 (2022):3488.PMID:35547749
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- Theranostics 14.16 (2024):6161.PMID:39431016
- Mater Horiz (2024).PMID:39189308
- J Control Release (2025):114187.PMID:40902670
- Mol Ther (2025).PMID:39810420
- Redox Biology (2025):103870.
- Mater Horiz (2024).PMID:39189308
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- Environ Sci Technol (2024).PMID:39364562
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- Cell Discov 6.1 (2020):96.PMID:33349633
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- J Control Release 349 (2022):254-268.PMID:35803328
- Water Res (2024):122403.PMID:39278116
- Redox Biol (2023):102983.PMID:38064762
- J Control Release 360 (2023):647-659.PMID:37406817
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- Research-China (2025).
- J Control Release 365 (2024):301-316.PMID:38007195
- J Control Release 379 (2025):89-104.PMID:39756690
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- Research-China (2025).
- Environ Sci Technol (2025).PMID:40743993
- J Control Release 373 (2024):749-765.PMID:39084465
- J Adv Res (2025).PMID:40373960
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- Research 8 (2025):0860.PMID:40862056
- Cell Discov 6.1 (2020):96.PMID:33349633
- EBioMedicine 99 (2024).PMID:38101299
- Research-China 8 (2025):0823.PMID:40822127
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- Acta Biomater 157 (2023):321-336.PMID:36481504
- Cell Rep Med 6.9 (2025).PMID:40961922
- Environmental Science & Technology (2025).PMID:40743993
- Cardiovascular Diabetology 24.1 (2025):338.PMID:40826463
- J Control Release 359 (2023):12-25.PMID:37244298
- Research 8 (2025):0854.PMID:40927753
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- Medcomm 6.9 (2025):e70365.PMID:40919132
- Sci Total Environ 878 (2023):162942.PMID:36940749
- J Adv Res (2025).
- Redox Biol 62 (2023):102663.PMID:36924682
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- Cancer Lett (2024):216765.PMID:38408604
- Adv Healthc Mater (2025):e01742.PMID:40751487
- Cell Death Dis (2025):680.PMID:41053142
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- Mater Today Bio (2025):102288.PMID:40978162
- Pharmacol Res 187 (2023):106563.PMID:36410674
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Mater Today Bio 32 (2025):101703.PMID:40230646
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- Cancer Lett 620 (2025):217685.PMID:40158720
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- Adv Healthc Mater (2024):2401061.PMID:38849128
- Adv Healthc Mater (2025):2500845.PMID:40400499
- Sci Total Environ 897 (2023):165514.PMID:37451464
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- Cell Death Dis 16.1 (2025):493.PMID:40615369
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- Rare Met. (2025):1-23.
- Mater Today Bio (2025):101901.PMID:40520551
- Acta Biomater (2024).PMID:38452962
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Cardiovasc Res 121.2 (2025):324-338.PMID:39658102
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- Acta Biomater (2025).PMID:40946735
- ENGINEERING-PRC (2025).
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- J Immunother Cancer 13.6 (2025):e011717.PMID:40473272
- Adv Healthc Mater (2025):e02762.PMID:41070830
- Mater Today Bio (2025):102288.
- Cell Death Dis 16.1 (2025):634.PMID:40841355
- View-China (2025):20240103.
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Food Chem (2025):146103.PMID:18830861
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Mater Today-Bio (2025):102420.
- Acs Appl Mater Inter 15.32 (2023).PMID:37542453
- Pharmacol Res (2024):107460.PMID:39393436
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Environ Pollut 338 (2023):122581.PMID:37748638
- Mater. Today Bio (2025):101703.
- Environ Pollut 334 (2023):122148.PMID:37419204
- Genes Dis (2025):101732.PMID:37815978
- CANCER LETT (2025):217685.
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Cancer Lett 611 (2025):217418.PMID:39725146
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Cancer Lett (2024):217418.PMID:39725146
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Front Immunol 14 (2023):1130308.PMID:37006248
- Acta Biomater (2025).PMID:40024424
- Brit J Cancer (2024):1-9.PMID:38594370
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Biomark Res 11.1 (2023):3PMID:36611218
- J Colloid Interf Sci (2025):137652.
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Acta Biomater (2025).PMID:39952883
- Acs Appl Mater Inter (2024).PMID:38345297
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- Int J Biol Macromol (2025):146723.PMID:40784392
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- J Colloid Interf Sci (2025):.PMID:39755016
- Food Chem (2024):139505.PMID:38703732
- Int J Biol Macromol (2025):145368PMID:40541884
- Sci Rep-Uk 15.1 (2025):1-14.PMID:40450025
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Acs Sensors (2024).PMID:38958530
- Mater Today Bio (2025):101901.
- Acta Pharmacol. Sin. (2025):1-13.PMID:40903541
- Phytomedicine 118 (2023):154944.PMID:37393830
- Mater Today Bio (2024):101019.PMID:38516170
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Food Res Int 204 (2025):115940.PMID:39986784
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Int J Biol Macromol (2025):140602.PMID:39922352
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Npj Precis Oncol 9.1 (2025):269.PMID:40753128
- Phytomedicine (2025):157371.
- Free Radical Bio Med (2025).PMID:40782974
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Free Radical Bio Med (2025).PMID:40782974
- Int J Biol Macromol (2025):147767.PMID:40972920
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol (2024):129172.PMID:38176496
- Int J Biol Macromol (2025):148198.PMID:41072677
- Int J Biol Macromol (2024):131928.PMID:38688339
- View:20250139.
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Phytomedicine 122 (2024):155091.PMID:37844378
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Environ Res (2024):118221.PMID:38246300
- Phytomedicine (2023):155270.PMID:38096717
- Phytomedicine (2025):157402PMID:41101069
- Int J Biol Macromol (2025):148033.PMID:41038469
- Int J Biol Macromol (2024):137561.PMID:39537068
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Phytomedicine (2025):157223.PMID:40929882
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Int J Biol Macromol (2025):147167.PMID:40889659
- Int J Biol Macromol (2024):133667.PMID:38969038
- Sci Rep-Uk 15.1 (2025):1-16.PMID:40436970
- Int. J. Biol. Macromol. (2025):143759.
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Int J Biol Macromol (2025):141767.
- Int J Biol Macromol (2025):140632.PMID:39909240
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- INT J BIOL SCI 21.7 (2025):3099-3121.
- Int J Biol Macromol (2024):135562.PMID:39276884
- Acs Appl Mater Inter (2025).PMID:40025657
- Int Immunopharmacol 158 (2025):114885.PMID:40383096
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Front Immunol 16 (2025):1569210.PMID:40396173
- Antivir Res 205 (2022):105381.PMID:35835291
- Acs Appl Mater Inter (2024).PMID:39448903
- Int J Biol Sci 21.4 (2025):1837-1851.
- Acs Appl Mater Inter (2025).PMID:39853325
- CANCER IMMUNOL RES (2025).PMID:40323348
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Int J Biol Macromol (2025):141146.PMID:39986528
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Int J Biol Macromol(2023):125130.PMID:37263336
- Int. J. Biol. Markers (2025):143683.PMID:40318724
- Int J Biol Macromol (2025):140374.PMID:39880265
- Sci Rep-Uk 15.1 (2025):1-17.PMID:40383858
- Sci China Life Sci (2025):1-11.PMID:39821161
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Nanoscale Horiz (2025).
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Acs Omega (2025).
- Int J Biol Macromol (2024):135979.PMID:39332550
- Int. J. Biol. Macromol. (2025):142238.PMID:40112979
- Acs Appl Mater Inter (2024).PMID:39320506
- Cell Death Dis 16.1 (2025):240.PMID:40175350
- Oncogene (2023):1-13.PMID:37138031
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Neural Regen Res (2025):10-4103.PMID:41017725
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Phytomedicine (2025):156598.
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Neural Regen Res (2025):10-4103.PMID:41017682
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Npj Precis Oncol 9.1 (2025):112.PMID:40240582
- Antioxidants-Basel 14.8 (2025):915.
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Cell Rep 44.3 (2025).PMID:39977268
- Chem-Biol Interact (2025):111576.PMID:40456372
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- J Med Chem (2024).PMID:39292661
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Int J Nanomed 20 (2025):293-308.
- Embo Rep (2025):1-23. PMID:40185977
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Appl Mater Today 47 (2025):102949.
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- Virol Sin (2023).PMID:37331658
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- J Gastroenterol (2023):1-14.PMID:37150773
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Cell Death Discov 11.1 (2025):427.PMID:41052997
- Phytother Res (2024).PMID:38558449
- Diabetes (2025):db250132.PMID:40906541
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Life Sci 308 (2022):120925.PMID:36057399
- J. Environ. Chem. Eng. (2025):116286.
- AGING DIS 17.1 (2026):2.PMID:40072367
- J Med Virol 97.3 (2025):e70267.
- Int J Nanomed (2025):4535-4550.PMID:4023652
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- Life Sci 312 (2023):121092.PMID:36279968
- Inflamm Res 74.1 (2025):1-22.PMID:40439750
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Fertil Steril (2023).PMID:37178109
- Phytomedicine (2025):156860.
- J Environ Chem Eng 13.3 (2025):116286.
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- Phytomedicine 130 (2024):155744.PMID:38763011
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- J Med Chem (2024).PMID:38315032
- Emerg Microbes Infec (2025):2522877.PMID:40536397
- Biomed Pharmacother 189 (2025):118248.PMID:40561593
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Front Nutr 9 (2022):812623.PMID:35419394
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- J Med Chem (2025).PMID:40500735
- Oncogene (2025):1-15.PMID:39920289
- Phytomedicine (2024):155859.PMID:38972239
- Stem Cell Res Ther 16.1 (2025):239.PMID:40361250
- Phytomedicine (2025):156928.
- Free Radical Bio Med (2024).PMID:38367927
- J Med Chem (2025).PMID:39842821
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Cell Death Discov 11.1 (2025):1-12.PMID:40456746
- Arch Toxicol (2025):1-17.PMID:40464975
- Biomed Pharmacother 188 (2025):118217.PMID:40435839
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Int J Nanomed (2025):11295-11314.PMID:40989888
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Front Immunol 13 (2022):902515.PMID:35874682
- Front Immunol 13 (2022):986214.PMID:36341437
- Food Res Int (2025):115940.
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- J Anim Sci Biotechno 16.1 (2025):121.PMID:40887645
- J Med Chem 68.3 (2025):3356-3372.PMID:39842821
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Oncogene (2025):1-17.PMID:40968253
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Phytomedicine (2025):156515.PMID:39983438
- Iscience (2025).
- Stem Cell Res Ther 16.1 (2025):1-18.PMID:40361250
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- J Polym Environ (2025):1-16.
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Cell Death Discov 11.1 (2025):1-16.PMID:40399275
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Front Immunol 14 (2023):1111494.PMID:36817451
- Front Immunol 14 (2023).PMID:37662906
- Brit J Pharmacol (2024).PMID:38715438
- Mol Med 30.1 (2024):14.PMID:38254010
- Phytother Res (2023).PMID:37086359
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Front Oncol 13 (2023):1120103.PMID:36959804
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- J Agr Food Chem 73.14 (2025).PMID:40152883
- Phytother Res (2023).PMID:37246830
- Exp Neurol 359 (2023):114266.PMID:36336032
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Biochem Pharmacol (2023):115632.PMID:37263300
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Cns Neurosci Ther (2023).PMID:37452510
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Front Oncol 12 (2022):770628.PMID:35372056
- Front Oncol 12 (2022):858598.PMID:35321435
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Mol Med 30 (2024):260.PMID:39707194
- Int J Pharmaceut (2023):123142.PMID:37328119
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Front Oncol 12 (2022):858598.PMID:35321435
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- Cells 11.24 (2022):4094.PMID:36552856
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Resp Res 24.1 (2023):216.PMID:37674165
- J Gastroenterol (2025):1-17.PMID:41060436
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Front Oncol 13 (2023):1132424.PMID:37251940
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Front Pharmacol 13 (2022):927488.PMID:35935870
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Front Pharmacol 12 (2021):610158.PMID:33762939
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Cells 11.23 (2022):3816.PMID:36497076
- Cancer Gene Ther (2021)1-12.PMID:33888871
- J Agr Food Chem (2023).PMID:37922022
- Mbio (2023):e01688-23.PMID:37882780
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Biochem Pharmacol (2024):116044.PMID:38336157
- Front Immunol 15 (2024):1455996.PMID:39376562
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Apoptosis (2025):1-17.PMID:40347321
- Front Immunol 16 (2025):1569210.
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Apoptosis (2024):1-19.PMID:39097858
- Mol Med 31.1 (2025):1-15.PMID:40369420
- Front Pharmacol 11 (2020):16.PMID:32140106
- Mol Med 31.1 (2025):1-15.PMID:40405066
- Antioxid Redox Sign (2025).PMID:40455659
- Lab Chip (2024).PMID:38939907
- Jci Insight (2024). PMID:38935435
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Front Immunol 16 (2025):1591912.
- BREAST CANCER RES 27.1 (2025):61.PMID:40270028
- J Nutr Biochem (2024):109678.PMID:38844080
- Cell Biosci 15.1 (2025):95.PMID:40615893
- Front Immunol 16 (2025):1618342.
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Mol Med 31.1 (2025):188.PMID:40369420
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- Front Immunol 16 (2025):1591912.PMID:40655141
- Mol Med 31.1 (2025):200.PMID:40405066
- Mol Med 31.1 (2025):258.PMID:40681992
- Phytother Res (2025).PMID:40675558
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Front Immunol 16 (2025):1619733.PMID:40842984
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- J Mater Chem B (2024).PMID:39119756
- Jci insight 9.15 (2024):PMID:38935435
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- J Agr Food Chem (2025).PMID:39962827
- Int J Mol Med 55.3 (2025):1-17.
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Talanta (2025):127591.PMID:39847915
- J Invest Dermatol (2025).PMID:39892773
- J Transl Med 23.1 (2025):131.PMID:39885513
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Immunol 15 (2024):1375781.PMID:39391314
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Biomater Adv (2025):214257.PMID:40023084
- Biomater Adv (2024):214069.PMID:39447240
- J Agr Food Chem (2025).PMID:40017402
- Mol Cell Proteomics (2025):100930.PMID:40024376
- Microbiol Res (2024):127927.PMID:39393129
- J Invest Dermatol (2025).PMID:39892773
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Immunol 15 (2024):1375781.PMID:39391314
- Front. Immunol. 16 (2025):1556715.
- J Agr Food Chem (2025).PMID:40152883
- Biomacromolecules (2025).
- Front Immunol 16 (2025):1521965.PMID:40191190
- Mol Med 30.1 (2024):1-18.PMID:39266965
- MOL MED 31.1 (2025):126.PMID:40186145
- Phytother. Res. 39.3 (2025):1355-1371.PMID:39764683
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Microbiol Res (2025):128183.
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Neurotoxicol Teratol (2025):107500.PMID:40456500
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Acs Biomater Sci Eng (2024).PMID:38445959
- Acs Biomater Sci Eng (2024).PMID:38446137
- Life Sci (2024):122483.PMID:38307238
- Acs Biomater Sci Eng (2025).PMID:40891613
- Am J Chinese Med (2024):1-23.PMID:38490807
- J Agr Food Chem (2025).PMID:40899763
- Cell Oncol (2025):1-17.PMID:41051595
- Front Oncol 12 (2022):961653.PMID:36457504
- Front Oncol 12 (2022):1043161.PMID:36439418
- Antivir Ther 30.3 (2025):13596535251345953.PMID:40434182
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Int. J. Mol. Sci. 26.9 (2025):4325.
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- CANCER CELL INT 25.1 (2025):1-24.PMID:40296031
- Acs Biomater Sci Eng (2024).PMID:39164198
- Molecules 27.17 (2022):5698.PMID:36080465
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- ACS Appl. Nano Mater. (2025).
- Eur J Pharmacol (2025):178123.PMID:40914268
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Transl Oncol 56 (2025):102396.PMID:40239242
- Glia (2024).PMID:39610064
- J Oncol 2022 (2022).PMID:36281290
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- Clin Immunol (2024):110308.PMID:39002794
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Mol Neurobiol (2025):1-16.PMID:40402409
- Microorganisms 11.5 (2023):1268.PMID:37317242
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Int Immunopharmacol 159 (2025):114886.PMID:40424656
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Cns Neurosci Ther 31.5 (2025):e70437.PMID:40400263
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Environ Toxicol (2023).PMID:38069587
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- Mol Neurobiol (2024):1-18.PMID:38995443
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Biochem Pharmacol (2024):116438.PMID:39025409
- J Ethnopharmacol (2024):119272.PMID:39716512
- Food Funct. (2025).
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- J Ethnopharmacol (2024):118685.PMID:39127116
- J Virol (2023):e00549-23.PMID:37222617
- Food Biosci (2025):106564.
- J Dent (2024):105436.PMID:39488296
- J Drug Deliv Sci Tec 107 (2025):106841.
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- J Ethnopharmacol (2024):117865.PMID:38369066
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- Bioengineering 9.9 (2022):433.PMID:36134979
- Life Sci (2024):123148.PMID:39447733
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- Nutrients 17.5 (2025):923.PMID:40077793
- Commun Biol 8.1 (2025):71.PMID:39820362
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Eur J Pharmacol 998 (2025):177497.PMID:40058753
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- J Drug Deliv Sci Tec 104 (2025) 106577.
- J Agr Food Res (2025):101694.
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Food Funct (2025).PMID:40421817
- J Ethnopharmacol 347 (2025).PMID:40187623
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- Exp Neurol (2025):115252.PMID:40221008
- Molecules 27.14 (2022):4603.PMID:35889477
- J Ethnopharmacol (2024):119073.PMID:39522846
- J Dent (2024):105436.PMID:39488296
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Mol. Nutr. Food Res. (2025):e70053.PMID:40177855
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- J. Ethnopharmacol. (2025):119727.PMID:40187623
- J Am Heart Assoc: 14.16 (2025):e040093.PMID:40767292
- J Oncol 2022 (2022).PMID:36213831
- J Nutr Biochem (2024):109780.PMID:39395694
- T Nonferr Metal Soc 35.8 (2025):2726-2733.
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- J Ethnopharmacol (2024):117985.PMID:38417600
- J Ethnopharmacol (2024):117958.PMID:38395179
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- J. Drug Delivery Sci. Technol. (2025):106841.
- J oncol 2022 (2022).PMID:36385962
- Colloid Surface B (2025):114537.PMID:39879672
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Molecules 27.23 (2022):8568.PMID:36500666
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Arch Toxicol (2025):1-17.PMID:40464975
- Biochem Pharmacol (2024):116688.PMID:39617210
- Life Sci 254 (2020):117793.PMID:32416164
- Int Immunopharmacol 163 (2025):115226.PMID:40663811
- Mol Carcinogen (2023).PMID:37750597
- Am J Physiol-Gastr L (2024).PMID:38742280
- Front. Pharmacol. 16 (2025):1613560.PMID:40822457
- Int Immunopharmacol 165 (2025):115441.PMID:40911993
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- Int Immunopharmacol 162 (2025):115151.PMID:40609203
- Drug Des. Dev. Ther. (2025):5123-5141.PMID:40546656
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Radiother Oncol (2024):110686.PMID:39709027
- PLoS Pathog. 21.9 (2025):e1013492.PMID:40920846
- Chem-Biol Interact (2025):111630.PMID:40609922
- Invest Ophth Vis Sci 66.13 (2025).PMID:41099598
- Macromol Biosci (2024):2400003.PMID:38597147
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Front Nutr 12 (2025):1682308.PMID:41112749
- Cell Signal (2023):110987.PMID:38029946
- Nutrients17.20 (2025):3218.
- Bioorg Chem (2025):108926.PMID:40907438
- Pharmaceuticals-Base 18.8 (2025):1187.
- J Am Heart Assoc (2025):e040093.PMID:40767292
- Front Pharmacol 16 (2025):1613560.PMID:40822457
- J Ethnopharmacol (2024):118080.PMID:38521426
- Chem-Biol Interact (2025):111702.PMID:40812562
- Faseb J 38.7 (2024):e23591.PMID:38572579
- Glia (2025).PMID:40747821
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- Macromol Biosci (2024):2400003.PMID:38597147
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- Toxicology (2024):154018.PMID:39608440
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Cell Signal 113 (2024):110962.PMID:37931691
- Acs Appl Bio Mater (2024).PMID:38700956
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Environ Toxico (2024).PMID:38700384
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Molecules 28.6 (2023):2426.PMID:36985397
- Virulence 16.1 (2025):2500493.PMID:40521898
- Molecules 27.21 (2022):7183.PMID:36364008
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- J Oncol 2022 (2022):6459029PMID:36199788
- Drug Des Dev Ther (2025):5123-5141.
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- J Ethnopharmacol (2025):120157.PMID:40532799
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- J Ethnopharmacol (2023):116731.PMID:37277084
- Transl Oncol 47 (2024):102042.PMID:38924847
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Bioorg Chem (2025):108667.
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- Bioorg Chem (2025):108656.
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Transl Oncol 52 (2025):102256.PMID:39733744
- Int J Mol Sci 26.13 (2025):5999.
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- J Oncol 2022 (2022).PMID:36213838
- Arch Toxicol (2024):1-16.PMID:38971901
- Front Oncol 12 (2022):996080.PMID:36483054
- Neurochem Res (2023):PMID:37127800
- Front Genet 13 (2022):932973.PMID:36118847
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Zool Res 45.5 (2024).PMID:39147715
- Environ Toxicol (2024).PMID:39400944
- Toxicol Sci (2024):kfae054.PMID:38636494
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- J Biol Chem (2024):107499.PMID:38944125
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- J Neuro Oncol (2023):1-16.PMID:37351767
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Environ Toxicol (2023).PMID:37052456
- Endocrine (2024):1-14.PMID:38378893
- Gene (2023):148050.PMID:38042211
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Zool Res 45.5 (2024):1001.PMID:39147715
- Acta Derm-Venereol 104 (2024).PMID:38590175
- J Steroid Biochem (2023):106429.PMID:38035949
- Front Oncol 14 (2024):1440906.PMID:39346724
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- J Cancer 15.5 (2024):1397.PMID:38356722
- Metabolomics 20.5 (2024):112.PMID:39369160
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Bmc Complement Med 24 (2024).PMID:38783288
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- J Immunother (2024):10-1097.PMID:38847148
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Gerontology (2024).PMID:38168028
- Oral Dis (2024).PMID:38168877
- Neuroscience (2023).PMID:37286157
- Pediatr Res (2024):1-10.PMID:38658662
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Gene (2024):148399.PMID:38518902
- Cytokine 176 (2024):156507.PMID:38244240
- Front Genet 13 (2022):959109.PMID:36147489
- Endocrine (2024).PMID:38191984
- Heliyon 8.11 (2022).PMID:36353164
- Heliyon (2024).PMID:38707472
- Ann Transl Med 10.24 (2022).PMID:36660714
- Brain Res Bull (2024):111165.PMID:39667505
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Front Oncol 14 (2024):1471109.PMID:39582546
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Eur J Pharmacol (2024):176995.PMID:39277096
- Sci Rep-Uk 15.1 (2025):27517.PMID:40721473
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- J Mech Behav Biomed 167 (2025):106963.PMID:40120143
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- J Cancer 11.5 (2020):1162.PMID:31956362
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Sci Rep-Uk 15.1 (2025):18697.PMID:40436970
- Poultry Sci (2025):105339.PMID:40482626
- Microb Pathogenesis (2025):107720.PMID:40403987
- Sci. Rep. 15.1 (2025):15556.PMID:40319036
- Arch Biochem Biophys (2025):110352.PMID:39978618
- Food Chem Toxicol (2025):115488.PMID:40288513
- Faseb J 39.16 (2025):e70961.PMID:40827901
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- Front Pharmacol 16 (2025):1517221.
- J Oncol 2022 (2022).PMID:35518787
- Ann Surg Oncol (2025):1-20.PMID:40887570
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- Biol 14.6 (2025):594.
- Poultry Sci (2025):105818.
- Oncol Res 33.8 (2025):2085.PMID:40746890
- J Virol 99.8 (2025):e00498-25.PMID:40631894
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Exp Cell Res (2025):114674.PMID:40683587
- Bba-Mol Basis Dis (2025):168050.PMID:40946874
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- Faseb J39.7 (2025):e70530.PMID:40193045
- Mol Med Rep 31.5 (2025):138.PMID:40145553
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Front. Oncol. 15 (2025):1536473.PMID:40303992
- Front Pharmacol 16 (2025):1562839.PMID:40183104
- Frontiers in Pharmacology 16 (2025):1547685.
- Sci Rep-Uk 15.1 (2025):11639.PMID:40185911
- Cell Death Dis 16.1 (2025):287.PMID:40223081
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Cell Signal (2025):111815.PMID:40258578
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Sci Rep-Uk 15.1 (2025):13282.PMID:40247060
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Food Chem. Toxicol. (2025):115488.PMID:40288513
- J. Cell. Mol. Med. 29.8 (2025):e70476.PMID:40275529
- Probiotics Antimicro (2025):1-16.PMID:40366615
- J. Funct. Foods 128 (2025):106822.PMID:39486993
- J Biomed Mater Res A 113.3 (2025):e37893.PMID:40059713
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Front. Pharmacol. 16 (2025):1545498.
- Cell Signal (2025):112175.PMID:41106751
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Eur J Pharmacol (2025):177497.PMID:40058753
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Exp Cell Res (2025):114674.PMID:40683587
- Pestic Biochem Phys (2025):106728.
- Front Toxicol 7 (2025):1598185.PMID:40376450
- ACS Omega (2025).PMID:40686969
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Eur J Pharmacol (2025):177343.PMID:39900330
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Exp Cell Res (2025):114674.PMID:40683587
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- J Ovarian Res 18 (2025):168.PMID:40731365
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Bmc Genomics 26.1 (2025):706.PMID:40745632
- Probiotics Antimicro (2025):1-16.PMID:40366615
- Molecules 30.3 (2025):549.PMID:39942654
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- Iscience 28.7 (2025).
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- J Inflamm Res (2025):7401-7417.PMID:40503490
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Sci Rep-Uk 15.1 (2025):24303.PMID:40624204
- Sci Rep-Uk 15.1 (2025):794.
- Brain Res Bull (2025):111245.PMID:39924054
- Sci Rep-Uk 15.1 (2025):25039.PMID:40646181
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Sci Rep-Uk 15.1 (2025):26300.PMID:40683918
- Biomedicines 13.6 (2025):1315.PMID:40564034
- Sci Rep-Uk 15.1 (2025):30446.PMID:40830225
- Mol Neurobiol (2025):1-20.PMID:40742404
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- Poultry Sci (2025):105339.
- Biology 14.9 (2025)
- Ann Med 57.1 (2025):2523563.PMID:40579858
- Front Pharmacol 16 (2025):1565713.PMID:40474975
- Acs Omega (2025).
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Oncol Res 33.8 (2025):2085.PMID:40746890
- ONCOL LETT 29.6 (2025):1-12
- Toxicol-Lett-(2025).PMID:40854414
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- J Cancer 16.10 (2025):3048-3064.
- Comput Biol Chem (2025):108540.PMID:40483799
- Toxicon X (2025):100236.
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Carcinogenesis (2025):bgaf030.
- Hum Mol Genet (2024):ddae122.PMID:39216871
- Biochem Bioph Res Co (2025):151972.
- METABOLITES 15.5 (2025):290.
- Funct Integr Genomic 25.1 (2025):1-17.PMID:40608130
- Cancer Res Commun (2025).PMID:40601866
- Front Mater 12 (2025):1568591.
- Mol Biotechnol (2024):1-15.PMID:38771419
- CURR ISSUES MOL BIOL 47.5 (2025):314.
- Shock (2023):10-1097.PMID:37988072
- Chem Biol Drug Des 105.4 (2025):e70111.PMID:40247760
- Microvasc Res (2025):104833.PMID:40571189
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Mol Carcinogen (2025).PMID:40222040
- Cell Biochem Funct 43.7 (2025):e70097.PMID:40574709
- Oncol Res 32.6 (2024):1129.PMID:38827325
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Exp Eye Res (2025):110492.
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- J Mol Histol (2024):1-8.PMID:38758519
- Bmc Cancer 25.1 (2025):1205.PMID:40707929
- Pathol Res Pract (2025):156247.PMID:41045764
- Renal Failure 47.1 (2025):2548613.PMID:40887103
- Curr Issues Mol Biol 47.5 (2025):314.PMID:40699713
- Technol Cancer Res T 19 (2020).PMID:33111613
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Tissue Cell (2024):102477.PMID:39018712
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Microb Pathogenesis (2025):107720.PMID:40403987
- Plos One 20.8 (2025):e0329272.PMID:40758730
- RENAL FAILURE 47.1 (2025):2552913.PMID:40898827
- Toxicol Lett (2025).PMID:40412772
- Integr Cancer Ther 24 (2025).PMID:40944546
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Mol Carcinogen (2025).PMID:40794014
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Exp Eye Res (2025):110492.PMID:40541914
- Toxicology Letters (2025).PMID:40854414
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Biomarkers (2024):1-12.PMID:38568742
- J Integr Complement (2025).PMID:40459144
- J Orthop Surg Res 20.1 (2025):443.PMID:40319252
- Transbound Emerg Dis 2025.1 (2025).PMID:40692872
- Aesthet Plast Surg (2025):1-15.PMID:40180642
- J Pharm Pharmacol (2025):rgaf094.PMID:41042989
- Bmc Pregnancy Childb 25.1 (2025):1001.PMID:41034826
- Chem Biodivers (2025):e00918.PMID:40991575
- Plos One 20.6 (2025):e0317930.PMID:40455747
- Andrology-Us (2025).PMID:40862537
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- Luminescence 39.1 (2024):e4671.PMID:38286599
- J ORTHOP SURG RES 20.1 (2025):443.PMID:40319252
- Molecular brain 18.1 (2025):1-23.PMID:39962509
- Kaohsiung J Med Sci (2025):e70031.PMID:40387410
- Future Microbiol 0 (2024).PMID:38629914
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Cell Transplant 33 (2024).PMID:38334047
- Int J Chronic Obstr (2025):623-639.PMID:40092321
- Arch Biochem Biophys 766 (2025):110352.PMID:39978618
- Bba-Mol Cell Biol L 1870.5 (2025):159631.PMID:40379088
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Brain Res (2025):149942.PMID:40930451
- Gene 932 (2025):148898.PMID:39209182
- Microb Pathogenesis (2024):107055.PMID:39442820
- CURR DRUG DELIV (2025).PMID:39976030
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Clinics 77 (2022).PMID:35662010
- Genomics (2025):111009.PMID:39864635
- Int J Chronic Obstr (2025):623-639.
- Dis Markers 2022 (2022).PMID:35845132
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Shock (2023):10-1097.PMID:37179246
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- Virus Res 313 (2022):198748.PMID:35304133
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- MED ONCOL 42.4 (2025):1-13.PMID:40072654
- Dis Markers 2022 (2022).PMID:35845132
- Shock 59.3 (2023):426-433.PMID:36609531
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- J Sci Food Agr (2024).PMID:39394871
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Luminescence 40.2 (2025):e70095.PMID:39924164
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Pathogens 14.2 (2025):182.
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Toxicon (2025):108293.PMID:39999927
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- J Mech Behav Biomed (2025):106963.
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- Mol Med Rep 31.3 (2025):1-10.
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Pathogens 14.2 (2025):182.
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Tissue Cell 80 (2023):102001.PMID:36565506
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Heliyon (2024):.PMID:37461802
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- World J Gastro Oncol 17.3 (2025):102187.PMID:40092949
- Luminescence 40.2 (2025):e70116.PMID:39914999
- Dis Markers 2022 (2022).PMID:35968506
- Tissue Cell (2025): 102903.
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- S Afr J Bot 177 (2025):445-456.
- Mol. Med. Rep. 31.5 (2025):1-12.PMID:40145553
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Comb Chem High T Scr (2024).PMID:35894460
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- Peerj 13 (2025):e19550.PMID:40611940
- Peerj 13 (2025):e19550.PMID:40611940
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Oncol Res 33.1 (2024):103.PMID:39735676
- Translational Cancer Research 14.8 (2025).PMID:40950680
- Transplant Direct 11.7 (2025):e1829.PMID:40590007
- Women's Health Reports 6.1 (2025):803-815.
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Cell J 24.1 (2022):15.PMID:35182060
- Anim Biotechnol (2023):1-12.PMID:36756956
- Transl Cancer Res 14.5 (2025):2594.PMID:40530117
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Balk Med J 41.6 (2024).PMID:39319820
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Hematology 28.1 (2023):2220522.PMID:37272581
- Particul Sci Technol (2025):1-13.
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Balk Med J 41.6 (2024):491.PMID:39319820
- Immunobiology (2024):152832.PMID:38943814
- Andrologia 2025.1 (2025):4092625.
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Cancer Biomark 42.5 (2025):18758592241306263.
- Biochem Genet (2023):1-18.PMID:37148331
- Biochem Bioph Res Co (2025):152500.PMID:40858065
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- Immunobiology (2025):153090.
- World J Oncol (2024):.
- EXP LUNG RES 51.1 (2025):79-92.PMID:40889519
- J Interf Cytok Res (2025).PMID:40512525
- Neuroreport 33.10 (2022):413.PMID:35623086
- Genes Genom (2023):1-15.PMID:37318704
- J Integr Complement (2025).PMID:40459144
- Hematology 30.1 (2025):2523082.PMID:40611540
- Chin J Integr Med (2024):1-11.PMID:38941045
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- Int J Gen Med (2022):3199-3213.PMID:35342302
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- PeerJ 13 (2025):e19083.
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- J Obstet Gynaecol Re PMID:39169658
- Vet Parasitol (2024):110284.PMID:39126893
- Fitoterapia (2024):106245.PMID:39393711
- TRANSL ANDROL UROL 14.2 (2025).PMID:40114844
- J Int Med Res 49.3 (2021).PMID:33730930
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Chin J Integr Med (2025):1-10.PMID:40338446
- Asian J Urol (2025).
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Open Life Sci. 20.1 (2025):20221056.
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- J Int Med Res 48.4 (2020).PMID:31891283
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Mol Cell Probe (2025):102031.
- J Int Med Res 48.4 (2020).PMID:31891283
- Oncol Lett 29.6 (2025):276.PMID:40247989
- Cell J 25.8 (2023):554.PMID:37641417
- Int J Gen Med (2022):3199-3213.PMID:35342302
- AESTHET PLAST SURG (2025):1-15.PMID:40180642
- J Obstet Gynaecol Re PMID:39169658
- Cell J 24.1 (2022):15.PMID:35182060
- Vet Parasitol 331 (2024):110284.PMID:39126893
- Toxicon 257 (2025):108293.PMID:39999927
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Vet Microbiol (2025):110495.
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- Transl Cancer Res 13.4 (2024).PMID:38737693
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Crit Rev Eukar Gene (2025).
- Transpl P 52.1 (2020):398-405.PMID:31928781
- J Cardiothorac Surg 20 (2025):270.PMID:40555993
- Iran J Immunol (2023).PMID:37865874
- Jove-J Vis Exp 220 (2025):e68581.
- J Herbs Spices Med P (2025):1-16.
- Medicine 104.41 (2025):e45095.PMID:41088697
- J Cancer Metas Treat (2024).
- Int J Mol Sci 25.19 (2024):10496.
- J Pharm Anal (2024):101053.
- Drug Resist Update (2024):101161.
- Mater Res Express 7.2 (2020):025401.
- J Integr Med-Jim (2024).
- Carbohyd Polym (2024):122897.
- Int J Mol Sci 25.19 (2024):10339.
- Indian J Pharm Sci 86.3 (2024).
- Toxins 16.7 (2024):319.
- Drug Des Dev Ther (2024):5841-5851.
- Front Pharmacol 15 (2024):1384141@0.jpg
- J Tradit Compl Med (2024).
- J Hazard Mater (2024) 135735.
- Biosens Bioelectron (2024):116875.
- Pharmaceuticals-Base 17.10 (2024):1295.
- BioRxiv (2025):2025-06.
- Acs Appl Mater Inter (2024).PMID:39167710
- Bioact Mater 43 (2025):32-47.
- Talanta (2024):126381.
- J Cancer 15.13 (2024):4244-4258.
- Nutrients 16.14 (2024):2346.
- J Funct Foods 123 (2024):106621.
- Mol Cell Biochem (2024) 1-13.
- Nutrients 16.14 (2024):2314.
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Acs Omega (2024).
- Front Pharmacol 15:1453938.
- J Transl Med 22.1 (2024):1-16.
- Heliyon (2024).
- J Nutr Biochem (2024):109769.PMID:9276944
- Phytomedicine (2024):156091.
- Chin Herb Med (2024).
- Diss. University of Kansas, 2025.
- Int J Biol Sci 20.12 (2024):4713-4730.
- Cell Biomaterials (2025):
- Netw Model Anal Hlth 13.1 (2024):1-15.
- Faseb J 38.15 (2024):e23876.
- Bioorg Chem (2024):107731.
- Green Process Synth 13.1 (2024):20240050.
- hLife (2024).
- Acs Omega (2024).
- Int J Bioprinting (2024).
- Adv Funct Mater 29.50 (2019):1906690.
- Biomedicines 12.11 (2024):2543.
- Gene (2024) 149056.
- Ecotox Environ Safe 286 (2024):117233.
- scienceasia (2024).
- Phytother Res 34.4 (2020):836-845.
- J Hazard Mater (2024):136113.
- New J Chem 48.11 (2024):5068-5073.
- bioRxiv (2025):2025-01.
- Small (2024):2402308.PMID:3911
- Bioact Mater 36 (2024):524-540.
- Heliyon (2024).
- Rev Bras Farmacogn (2024):1-7.
- Viruses 16.8 (2024):1239.
- Front Bioeng Biotech 12 (2024):1460870.
- Mater Express 10.1 (2020):102-111.
- Acs Appl Nano Mater (2024).
- Int J Mol Sci 25.15 (2024):8340.
- Bioact Mater 44 (2025):220-235.
- Mol Ther Nucl Acids (2020).
- Chem Eng J (2024):156542.
- ACS Appl. Eng. Mater. (2025).
- J Transl Med 22.1 (2024) 1-16.
- Antioxidants 13.11 (2024) 1320.
- Antioxidants-Basel 13.11 (2024):1289.
- Am J Cancer Res (2024):2852-2867.
- Heliyon (2024).
- Biomed Pharmacother 179 (2024):117370.
- bioRxiv (2024) 2024-10.
- Int J Mol Sci 25.20 (2024):11184.
- Cell Biomaterials (2025).
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Tissue Cell 76 (2022).PMID:35182988
- Nano Today 41 (2021):101326.
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Iscience 26.9 (2023).PMID:37670789
- Front Microbiol 14 (2023).PMID:37645224
- Bio-Des Manuf 5.2 (2022):358-370.
- Phytochem Lett 47 (2022):174-179.
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Tissue Cell 74 (2022):101680.PMID:34808429
- Nano Today 43 (2022):101416.
- Nanophotonics 11.22 (2022):5089-5100.
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Front Oncol 12 (2022):851300.PMID:35392243
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- J Cancer 13.6 (2022):1808.PMID:35399733
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Front Mar Sci 9 (2022):861117.
- Front Pharmacol 13 (2022):899775.PMID:35571096
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Clin Transl Disc 2.2 (2022):e49.
- Cells 10.9 (2021):2399.PMID:34572049
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Fiber Polym (2022):1-9.
- Biomed Res Int 2021 (2021).PMID:34373837
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Chem Eng J 474 (2023):145358.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Nano Res (2022):1-8.
- Appl Entomol Zool 58.4 (2023):303-313.
- Biocell 47.8 (2023).
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Phytochem Lett 46 (2021):79-89.
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- J Environ Pathol Tox 42 (2023).PMID:36749091
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- Crystals 13.7 (2023):1067.
- PeerJ 9 (2021):e11482.PMID:34820154
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Acta Trop 232 (2022):106519.PMID:35584779
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Adv Funct Mater (2023):2214998.
- Oncol Lett 26.1 (2023):1-17.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Mater Today Chem 27 (2023):101331.
- Ceram Int 49.15 (2023):25953-25963.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- Aquaculture 564 (2023):739060.
- Mol Cell Toxicol (2022):1-11.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Sensor Actuat B-Chem 381 (2023):133437.
- bioRxiv (2023):2023-05.PMID:37292976
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Mol Med 29.1 (2023):6.PMID:36647009
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- Int J Pept Res Ther 29.2 (2023):19.
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- J Inflamm Res (2023):1045-1057.PMID:36936349
- View-China 4.2 (2023):20220052.
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Cells 11.22 (2022):3580.PMID:36429010
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Phytomedicine 103 (2022):154199.PMID:35679793
- Foods 11.11 (2022):1575.PMID:35681325
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Mater Today Adv 15 (2022):100271.
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- bioRxiv (2022):2022-04.
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Phytomedicine 105 (2022):154330.PMID:35905566
- J Oncol 2022 (2022).PMID:35909906
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Viruses 14.8 (2022):1783.PMID:36016405
- J Oncol 2022 (2022).PMID:36059813
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Molecules 27.16 (2022):5337.PMID:36014573
- Cancers 14.19 (2022):4645.PMID:36230568
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Cancers 14.21 (2022):5218.PMID:36358640
- Int J Nanomed (2023):5423-5440.PMID:37767196
- Appl Entomol Zool (2022):1-14.
- Heliyon (2024).
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Redox Biol (2024):103143.
- Nanoscale (2024).
- J Agr Food Chem (2024).
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- bioRxiv (2025):2025-08.
- Exp Ther Med 27.5 (2024):1-16.
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Mol Ther-Nucl Acids (2020).
- Mater Design (2024):112812.
- Heliyon (2024).
- bioRxiv (2025):2025-08.
- bioRxiv (2025):2025-08.
- J Funct Foods 114 (2024):106076.
- Front Immunol 15 (2024):1326137.
- Antioxidants Basel 13.3 (2024):264.
- New J Chem (2024).
- Kaohsiung J Med Sci (2024).PMID:38340032
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- J Ethnopharmacol (2024):117867.PMID: 38342155
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Acs Appl Opt Mater (2024).
- Acs Pharmacol Transl (2024).
- Bladder 12.2 (2025):e21200036.PMID:40747461
- Am J Chinese Med (2025):1-20.PMID:40646505
- Front Oncol 10 (2020):387.
- BioRxiv (2025):2025-06.
- Pharmaceutics 16.6 (2024):744.
- Phytomedicine (2024):155767.
- Molecular Therapy Oncology (2024).
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- Theranostics 14.7 (2024):2687.
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Phytomedicine (2024):155744.
- bioRxiv (2024):2024-05.
- Adv Funct Mater (2024):2402663.
- BioRxiv (2025):2025-01.PMID:39975379
- Adv Funct Mater (2024):2400489
- Transl Cancer Res 13.4 (2024).
- Phytomedicine (2024):155656.
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Seoul University Graduate Schoo2025.
- Biol 14.7 (2025):780.PMID:40723340
- Pharmaceuticals-Base 17.4 (2024):515.
- Cells 13.9 (2024):728.
- Applied Sciences 14.8 (2024):3186.
- Front Immunol 15 (2024):1347683.PMID:38343537
- bioRxiv (2024):2024-02.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Exp Eye Res 209 (2021):108642.PMID:34058232
- Front Immunol 14 (2023).PMID:37901236
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- Biochip J (2023):1-10.
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Mol Cell Toxicol (2023):1-10.
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Crit Rev Eukar Gene 34 (2024).
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Sensor Actuat B Chem 394 (2023):134396.
- J Inflamm Res 14 (2021):2445.
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- HemaSphere 5.7 (2021).PMID:34136753
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- Food Hydrocolloid 120 (2021):106980.
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- J Clean Prod 315 (2021):128201.
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Phytomedicine 86 (2021):153565.PMID:33945919
- Mater Today Bio (2024):100958.
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- Dis Markers 2022 (2022).
- Int J Biol Macromol 307 (2025).PMID:40112979
- Int J Mol Sci 25.2 (2024):919.
- Sensors & Diagnostics (2024).
- Phytomedicine (2024):155347.
- Adv Funct Mater (2024):2305827.
- Adv Funct Mater (2023):2309690.
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Pharmaceutics (2023) 15(12):2713.
- Front Pharmacol 11 (2021):618262.PMID:33551818
- J Biol Chem 297.2 (2021).PMID:33722608
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- Food Sci Nutr (2023).
- Biomaterials 272 (2021):120757.PMID:33798960
- Biocell 47.8 (2023).
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Ann Hematol (2023):1-12.
- Int J Mol Sci 25.24 (2024):13439.
细胞计数试剂盒-8(CCK-8)使用WST-8(2-(2-甲氧基-4-硝基苯基)-3-(4-硝基苯基)-5-(2,4-二磺酚基)-2H-tetrazolium,单钠盐),在存在电子载体1-Methoxy PMS的情况下,产生水溶性福尔马定染料进行方便的测定。 CCK-8溶液直接加入到细胞中,无需预先混合组分。 WST-8被细胞脱氢酶生物还原为可溶于组织培养液的橙色福尔马定产物。 产生的福尔马定量与活着的细胞数量成正比。由于CCK-8溶液非常稳定且具有很小的细胞毒性,因此可以进行更长时间(例如24至48小时)的孵育。
细胞计数试剂盒 - 8允许灵敏度高、用于增殖和毒性测定中确定存活细胞数量的显色法检测。 检测灵敏度比MTT、XTT或MTS等任何其他四唑盐都要高。

图1:Cell Counting Kit-8(CCK-8)的工作机制。
细胞数量确定
1.将细胞悬浮液(100μL/孔)接种在96洞孔板中。将板在潮湿的培养箱中预孵育(例如,在37℃,5%CO2下)。
2.向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
3.将培养板在培养箱中孵育1-4小时。
4.使用酶标仪测量450 nm处的吸光度。
细胞增殖和细胞毒性测定
1.将种子细胞以103-104个细胞/孔的密度在96孔板中在100μL培养基中培养。将细胞在CO2培养箱中于37℃培养24小时。
2.将不同浓度的待测物质加入板中。
3.将培养板在培养箱中孵育适当的时间(例如,6,12,24或48小时)。
4.使用重复移液器向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
5.将培养板在培养箱中孵育1-4小时。
6.在读取孔板之前,重要的是在轨道振动器上轻轻混合1分钟,以确保颜色均匀分布。
7.使用酶标仪测量450 nm处的吸光度。
数据分析
统计分析有几种方法,您可以选择使用O.D.值或细胞数量,我们提供其中一种方法。
细胞存活率(%)= [(As-Ab)/(Ac-Ab)]×100
抑制率(%)= [(Ac-As)/(Ac-Ab)]×100
As =实验孔吸光度(含有细胞,培养基,CCK-8和待测化合物的孔的吸光度)。
Ab =空白孔吸光度(含有培养基和CCK-8的孔的吸光度)。
Ac =对照孔吸光度(含有细胞,培养基和CCK-8的孔的吸光度)。
制作标准曲线
1. 细胞计数板计数细胞悬液中的细胞数。
2. 使用培养基,等比稀释细胞悬液为一个浓度梯度,通常需要5-7个浓度梯度,每组几个复孔。然后接种细胞。(注意每孔的细胞数量。如果您将细胞悬液稀释在管中,在加入培养板的孔之前,请小心再次混匀细胞。每孔中细胞悬液的体积应该是一致的。)
3. 培养直至细胞贴壁(通常2-4小时),然后每100 μl培养基加入10 μl CCK-8。继续孵育1-4小时,用酶标仪测量450nm处的吸光度。制作出一条以细胞数为X轴坐标,O.D.值为Y轴坐标的标准曲线。
可以基于该曲线确定待测样品的细胞数。使用此标准曲线的先决条件是培养检测条件相同。
注意事项
1. 确保药物和CCK8均匀分布在培养基中。
2. 细胞增殖越多, 颜色越深; 细胞毒性越强,颜色越浅。
3. 对于贴壁细胞,每孔至少需要1000个细胞(100 μl培养基)。对于白细胞,由于灵敏度较低,每孔至少需要2500个细胞(100 μl培养基)。推荐的96孔板每孔最大细胞数为25000。如果使用24孔或6孔板进行该检测,请计算相应的每孔的细胞数,并调整CCK-8的体积,使其为每孔总液体体积的10%。
4. 因为CCK8测定是基于活细胞中的脱氢酶活性,影响脱氢酶活性的条件或化学物质可能导致实际活细胞数与使用CCK-8测定活细胞数之间有差异。
5. WST-8可能与还原剂反应生成WST-8 formazan。如果使用还原剂 (例如一些抗氧化剂)会干扰检测。如果待检测体系中存在较多的还原剂,需设法去除。
6. 孵育2小时后,背景O.D.值一般为0.1-0.2单位。
7. 注意不要在孔中引入气泡,因为它们会干扰O.D.值。
8. 如果您想对CCK8溶液进行灭菌,请使用0.2 μm的膜过滤溶液。
9. 孵育时间因孔中细胞的类型和数量而异。通常,白细胞着色较弱,因此可能需要较长的孵育时间(长达4小时)或大量细胞(~105细胞/孔)。
10. 如果细胞悬液中存在高浊度, 测量并减去样品在600nm或更高波长的O.D值。
11. CCK8不能用于细胞染色。
12. 培养基中的酚红不会影响实验结果,酚红的吸光度可以在计算时,通过扣除空白孔中本底的吸光度而消去,因此不会对检测造成影响。
13. CCK8的毒性非常低,在CCK8测定完成后,相同的细胞可用于其他细胞增殖测定,例如结晶紫测定,中性红测定或DNA荧光测定。(除非细胞极为稀少,不推荐。)
14. 该试剂盒可用于大肠杆菌,但不能用于酵母细胞。
15. 在读取平板之前,您可以在摇床上轻柔混匀。
16. 我们建议将细胞接种在靠近培养板中央的孔中,最外围一圈孔中的培养基容易蒸发,可以用PBS,水或培养基填充这些孔。
17. 如果您没有450nm滤光片。您也可以使用吸光度在430和490nm之间的滤光片, 450nm滤光片具有最佳灵敏度。
18. 测量450nm处的吸光度,如果您需要进行双波长测定,作为参考波长可以测定650nm处的吸光度。
19. 药物中金属离子的存在可能会影响CCK8的灵敏度。终浓度为1mM的氯化亚铅、氯化铁、硫酸铜会抑制 5%、15%、 90% 的显色反应,使灵敏度降低。如果终浓度是10mM的话,将会100%抑制。
常见问题
Q:如何做空白对照?
A:可以用加相应量细胞培养基和CCK-8但不加细胞的孔作为空白对照,若担心所使用的药物会干扰检测,需设置加相应量细胞培养液、药物和CCK-8但不加细胞的孔作为空白对照。
Q:只加CCK-8不加细胞的空白孔,数值上增?
A:在整个实验过程中,随着时间的增加,如果细胞培养时间较长,请注意蒸发问题。因为反应环境温度较高,会有部分液体挥发。空白组虽然没有细胞,但是随着液体的挥发,药物浓度相当于提高了,所以空白对照的数值也会有轻微的变化(但不会有明显的变化)。如果很在意空白对照的数值,可将96孔板外围一圈加培养基、水或PBS 保湿。同时,可以把96孔板置于培养箱内靠近水盘的位置以缓解蒸发。将96孔板外围两圈用PBS铺板,这样挥发先挥发周边的,可以对内部及空白对照的影响降至最低。
Q:一般多久测一次值?
A:预实验时可以在0.5、1、2和4小时后分别用酶标仪检测,然后选取吸光度范围比较适宜的一个时间点用于后续实验。
Q:加入CCK8后暂时不测OD值,可以如何处理暂时保存?能够保存多久?
A:如果需要暂时不测定OD值,可以向每孔中加入10ul 0.1M HCl溶液或者1% w/v的SDS溶液,避光保存在室温,24小时内吸光度不会发生变化。
Q:如何保存?
A:CCK-8溶液在避光、0-5℃的条件下可以保存1 年,若长期不用可在-20℃下避光保存2年。建议分装后保存于-20℃,使用时提前于4℃解冻,请避免反复冻融,否则增加背景值,干扰实验结果。
Q:是否需要更换培养基?
A:不需要,若药物影响比较小的情况可以不更换培养基,直接扣除培养基中加入药物后的空白吸收即可。
Q:待测物质有氧化性或还原性该做何处理?
A:本试剂盒的检测依赖于脱氢酶催化的反应,如果待测物质有氧化性或还原性,可在加CCK-8之前更换新鲜培养基,去掉药物的影响。
如果实验中有还原剂,请检查背景的OD值,即在不含细胞的培养基中加入药物,然后加入CCK-8试剂在一定时间内检测,和不加药物的培养基进行比较(只有CCK-8试剂),如果O.D值明显偏高,则说明有反应。
Q:如果培养基颜色或PH已变化,是否需要更换新的培养基?
A:加入CCK-8时,如果细胞培养时间较长,培养基颜色或pH值已变化,建议换用新鲜的培养基。
Q:适用细胞?
A:因为测线粒体酶,所以真核细胞,有线粒体的均可,例如单细胞,动物细胞。但有细胞壁的细胞,例如植物细胞,酵母细胞,底物进入细胞效率低,不推荐。
Q:线性不佳原因?
A:细胞不均;培养液蒸发;还原剂;气泡;孔板周围一圈不能用,除非只培养少于一天的时间;细胞数目很重要,太少信号会低。
Q:金属毒性?
A:可以检测金属毒性,最好做空白对照。
Q:适用于那些细胞?其他还有哪些细胞可用?生物被膜内的活菌 (流感嗜血杆菌和绿脓杆菌)?
A:所有哺乳动物的细胞,细菌一般没有检测CCK8的,可以染色法,或者流式,最常规的方法,有报道, 比浊法测OD600。
Q:是否可以替代Brud或EDU法检测细胞增殖?
A:虽然CCK8通过检测对生长期的细胞内的脱氢酶来反应细胞的活性,而胸腺嘧啶插入法通过核苷酸类似物的方式插入合成的DNA来检测细胞的活性,这几种方法是有一定关联性的,CCK8可替换胸腺嘧啶插入法来检测细胞增殖,并且检测更方便。
Q:空白孔数值偏高,有可能是培养基长菌吗?或者其他原因?
A:空白孔数值偏高一般认为染菌造成的,很少出现这种问题。
Q:CCK8能检测组织吗
A:不能检测组织。
Q:是否可以检测T细胞
A:可以,T细胞长的慢,需延长孵育时间。
Q:当两个细胞混合培养时(骨髓间充质细胞,另一个是悬浮T细胞),培养一段时间后,只测骨髓间充质干细胞的生长、增殖情况,请问用CCK-8能测吗?怎么做?
A:对于两种细胞的情况:
1)如果测定贴壁细胞的生长状况,那么可以把悬浮的T细胞转移掉,使用上述第二种方法测定。
2)如果T细胞对于间充质细胞的生长很关键,不能取走,那么测定的活性程度是总量,此时,需要对每一个孔的T细胞进行估算,如果每个培养条件下T细胞总量接近,或者T细胞含量很少,远远小于间充质细胞,也可以测定,使用对照孔可以去除T细胞的影响。
3)如果T细胞可以短时间内除去,可以找个灵敏度高的CCK-8,信号强,建议细胞量合适的情况下(每一个孔10000个),30分钟左右出读数结果,测 定后,可以将T细胞再加入培养孔。 这样做对细胞的生长影响不大。但是如果做动力学,那么要考虑的因素多一些。
Q:CCK-8是通过和细胞内的脱氢酶反应而反映着细胞数量,假如细胞已经死亡,而脱氢酶活性还有,那么如何计算细胞数量?
A:多数情况下,细胞死亡过程中,细胞内的成分会降解,脱氢酶会有部分释放,但是活性和活细胞比,比较低。举例说:100个细胞死亡20小时后,释放的脱氢酶活力,不足5个活细胞的脱氢酶活力,也就是说,这种情况带来的误差5%以内。而且,这种细胞死亡,对同种细胞来说,情况是一样的,一般都是在不同的孔间比较同种细胞,所以系统误差是一样的,即系统误差会彼此消减。
| 应用&特点 |
1) 细胞增殖测定 - GlpBio细胞计数试剂盒-8(CCK-8)是水溶性的,在培养中是稳定的,并且是无毒的。 2) 细胞活力测定 - 代谢活性和染料产生与改变的活力成比例地变化。 3) 细胞因子测定 - 测量细胞因子诱导的增殖。如果需要,可以在研究结束时回收细胞并扩增。 4) 细胞毒性测定 - 来自细胞毒性化学物质的细胞死亡对颜色发展没有影响,只有活细胞将试剂转化为比色指示剂。试剂本身具有可忽略的毒性,并且通常对细胞是安全的。 |
| 运输方式 | 蓝冰运输。 |
| 储存条件 | 储存在4°C避光,可稳定长达12个月。储存在-20°C避光,可稳定长达2年。 |
| 用途 | 仅供研究使用!不能用于人体。 |
| CCK-8 | MTT | MTS | SRB |
| Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
| Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
| Character | Liquid | Solid | Liquid | Liquid |
| Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
| Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
| Convenience | +++ | ++ | +++ | + |
| Detection speed | +++ | + | ++ | + |
| Repeatability | +++ | + | ++ | ++ |
| Stability | ++ | + | + | +++ |
-
Related Biological Data

Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data

LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data

Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data

Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data

Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data

H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data

After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data

Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.